Cotellic (cobimetinib) — Medica
Melanoma (unresectable, advanced, or metastatic) with BRAF V600 mutation
Initial criteria
- Patient is age ≥ 18 years
- Patient has unresectable, advanced, or metastatic melanoma
- Patient has BRAF V600 mutation-positive disease
- Medication is prescribed in combination with Zelboraf (vemurafenib tablets)
Approval duration
1 year